These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23719906)

  • 1. Morphometric analysis of Huntington's disease neurodegeneration in Drosophila.
    Song W; Smith MR; Syed A; Lukacsovich T; Barbaro BA; Purcell J; Bornemann DJ; Burke J; Marsh JL
    Methods Mol Biol; 2013; 1017():41-57. PubMed ID: 23719906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
    Wetzel R
    Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart.
    Melkani GC; Trujillo AS; Ramos R; Bodmer R; Bernstein SI; Ocorr K
    PLoS Genet; 2013; 9(12):e1004024. PubMed ID: 24367279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a transgenic model of Huntington's disease in a non-human primate.
    Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW
    Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.
    Drombosky KW; Rode S; Kodali R; Jacob TC; Palladino MJ; Wetzel R
    Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.
    Xiao G; Fan Q; Wang X; Zhou B
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14995-5000. PubMed ID: 23980182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.
    Zheng S; Ghitani N; Blackburn JS; Liu JP; Zeitlin SO
    Mol Brain; 2012 Aug; 5():28. PubMed ID: 22892315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
    Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
    PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR Spectroscopy-based Metabolomics of Drosophila Model of Huntington's Disease Suggests Altered Cell Energetics.
    Singh V; Sharma RK; Athilingam T; Sinha P; Sinha N; Thakur AK
    J Proteome Res; 2017 Oct; 16(10):3863-3872. PubMed ID: 28871787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tiny
    Rosas-Arellano A; Estrada-Mondragón A; Piña R; Mantellero CA; Castro MA
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Drosophila model of Huntington disease-like 2 exhibits nuclear toxicity and distinct pathogenic mechanisms from Huntington disease.
    Krench M; Cho RW; Littleton JT
    Hum Mol Genet; 2016 Aug; 25(15):3164-3177. PubMed ID: 27288455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
    Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila.
    Liévens JC; Rival T; Iché M; Chneiweiss H; Birman S
    Hum Mol Genet; 2005 Mar; 14(5):713-24. PubMed ID: 15677486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity.
    Krench M; Littleton JT
    Fly (Austin); 2013; 7(4):229-36. PubMed ID: 24022020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PolyQ-independent toxicity associated with novel translational products from CAG repeat expansions.
    Rudich P; Watkins S; Lamitina T
    PLoS One; 2020; 15(4):e0227464. PubMed ID: 32240172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
    van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
    BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.